Forex Education Symbols

(TSX = xxx.TO, TSX-V = xxx.V)

0.17 0 (+0.00%) 10/20/2017 2:20pm
Open: 0.19 Prev Close: 0.17
High: 0.19 Low: 0.17
Volume: 177000 Market Cap: 12.13M
Year High: 0.48 Year Low: 0.14
Stock Technical Analysis
Targets Six months: 0.22    One year: 0.25
Supports Support1: 0.14   Support2: 0.11
Resistances Resistance1: 0.18    Resistance2: 0.22 
Pivot Point 0.18 
Moving Averages MA(5): 0.18      MA(20): 0.18 

MA(100): 0.20      MA(250): 0.25 
MACD MACD(12,26):       Signal(12,26,9):  
Stochastic Oscillator %K(14,3): 23.33      %D(3): 36.67 
RSI RSI(14): 46.11 
52-Week High: 0.48  Low: 0.14  Change(%): -54.1
Average Volume(K) 3-Month: 9330  10-Days: 178
Moving Averages analysis
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
Bollinger Bands Analysis
AQS.V has closed above bottom band by 30.7%. Bollinger Bands are 10.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock News
Aequus Pharmaceuticals Initiates Promotional Efforts for VISTITAN™ in Canada
Thu, 28 Apr 2016 13:30:00 GMT

Aequus Pharmaceuticals Inc. Announces $2.0 to $4.0 Million Best Efforts Financing
Tue, 06 Sep 2016 12:00:00 GMT

Aequus Pharmaceuticals Lists on the TSX Venture Exchange and Appoints New Director
Tue, 17 Mar 2015 12:56:15 GMT

Aequus Pharmaceuticals and CDRD Announce Research Collaboration to Improve ...
Thu, 01 Jun 2017 15:00:00 GMT

Aequus Granted Chinese Patent for Once-Weekly Transdermal Aripiprazole
Tue, 10 Oct 2017 12:45:00 GMT

Aequus Pharmaceuticals Becomes Reporting Issuer
Sat, 21 Feb 2015 00:22:30 GMT

Stoxline Canada

Stock Chart Toronto

Option Calculator

EPS -0.090
EPS Est. Current Year -0.070
EPS Est. Next Year
EPS Est. Next Quarter
Forward EPS 1.#IO
Shares Out. (M) 71.35
Shares Float (M) 51.77
Book Value (p.s.) 0.070
PEG Ratio
Profit Margin
Operating Margin -504.82
Return on Assets (ttm) -92.8
Return on Equity (ttm) -202.0
Qtrly Rev. Growth 58.0
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.064
Qtrly Earnings Growth
Operating Cash Flow (M) -4.21
Levered Free Cash Flow (M) -2.69
P/E -1.89
P/E Growth Ratio
P/BV 2.43
P/S 606475008.00
P/CF -2.88